[肝癌转化疗法的术后安全性分析:单中心回顾性研究]

Z W Wei1, J Q Cai1

  • 1Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

概括

术后的转化疗法是最初无法切除的肝细胞癌 (HCC) 的可管理方法. 这种治疗提供了手术机会,并促进了HCC患者的长期存活.